Just Released: Project Call 2.1. Click here for details.

Latest News

SME Spotlight - Unum Therapeutics

February 28, 2018

Unum Therapeutics is a Cambridge, MA-based clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products based on its universal Antibody-Coupled T-cell Receptor (ACTR). ACTR therapies are designed to harness the power of a patient’s immune system to cure cancer. When combined with an antibody that recognizes a target on the surface of tumor cells, the ACTR receptor can direct an individual’s T-cells to kill the tumor. Unlike other approaches (such as CAR-T or TCR), in which a cell’s receptor is trained to treat a narrow set of tumors, our therapy is not restricted to a particular target and may be used in many different cancer types.

For more information on Unum Therapeutics, please visit Or, connect with members of the Unum team through the NIIMBL Community Portal.

Copyright 2017 NIIMBL. All rights reserved.

Department of Commerce National Institute of Standards and Technology Manufacturing USA USA Bio